COVID-19: Clinical Information and Treatment Guidelines   [open pdf - 0B]

From the Purpose: "The purpose of this document is to provide relevant clinical information and treatment guidelines on the COVID-19 [coronavirus disease] pandemic. - for pharmacists and the pharmacy workforce, both in a primary care context (i.e. community pharmacies and primary healthcare facilities) and in hospital settings, as well as for pharmacists working as clinical biologists in medical analysis laboratories, for example, as clinical biologists, and offer a set of references that may be consulted for more information. Coronavirus infections can be prevented and an outbreak can be stopped through the active engagement of decision-makers, healthcare professionals, the media and the community. This was demonstrated in previous coronavirus outbreakssuch asin 2003 with SARS-CoV (Severe Acute Respiratory Syndrome Coronavirus) or in 2012 with MERS-CoV (Middle East Respiratory Syndrome Coronavirus). This document aims to assist pharmacists and the pharmacy workforce in preventing the spread of the disease and contributing to its efficient management in the healthcare system."

International Pharmaceutical Federation
Retrieved From:
International Pharmaceutical Federation: https://www.fip.org/
Media Type:
Help with citations